MTLS Earnings Prediction
The chart below shows how MTLS performed 10 days before and after its earnings report, based on data from the past quarters. Typically, MTLS sees a +5.17% change in stock price 10 days leading up to the earnings, and a -5.38% change 10 days following the report. On the earnings day itself, the stock moves by -0.96%. This data can give you a slight idea of what to expect for the next quarter's release.
MTLS Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
68.65M
14.17%
-0.21%
Gross Margin
57.24%
2.14%
0.39%
Operating Margin
6.28%
62.27%
13.77%
Net Margin
4.43%
-33.58%
-21.31%
EPS
0.05
-28.57%
-28.57%
No Data Available
MTLS Earnings Analysis
Materialise NV Corporation (MTLS.O) Earnings Conference Call
Positive
Total Revenue Increase: Total revenue increased 14% to €68.7 million, demonstrating growth across all business segments compared to the third quarter of last year.
Medical Segment Growth: The medical segment grew by more than 24%, posting record high quarterly revenue figures.
EBIT Improvement Analysis: Adjusted EBIT increased to €4.4 million, representing 6.4% of revenue, a significant improvement from €2.3 million in the corresponding period of 2023.
Gross Margin Improvement: The gross margin improved to 57.2%, up from 56% for the comparable period of 2023, reflecting strong operational performance.
Medical Segment Revenue Increase: Year-to-date, the medical segment generated over €201 million in revenue, which is 5.4% above the same period in 2023.
Negative
Revenue Increase and Challenges: Total revenue increased by 14% to €68.7 million, but the manufacturing segment faced a challenging market environment, resulting in a 3% revenue growth compared to the third quarter of last year.
R&D Expense Increase: Operating expenses increased by €3.8 million or 11.8%, primarily due to higher R&D spending, which grew by 16% compared to last year.
Negative Financial Results: Net financial results amounted to a negative €1.1 million, primarily impacted by unfavorable currency exchange results of €1.8 million.
EBITDA Margin Improvement: The adjusted EBITDA margin for the quarter was 6.4%, compared to 3.9% last year, indicating a significant increase but still reflecting pressure on profitability.
Net Cash Position Decline: The net cash position at the end of the third quarter was €63.1 million, down by €4.4 million from the position at the end of the second quarter.
MTLS FAQs
How does MTLS typically perform around its earnings report dates?
Is Materialise NV (MTLS) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
MTLS Earning Call Sentiment
Materialise NV (MTLS) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
MTLS.O
5.47%Positive
The earnings call highlights strong financial performance with a 14% revenue increase, improved margins, and successful acquisitions. Despite some management ambiguity during the Q&A, the optimistic guidance, new partnerships, and ongoing investments suggest positive market sentiment. The medical segment's growth and strategic partnerships are key catalysts for a potential stock price increase, likely in the 2% to 8% range.
